Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - C4 Therapeutics, Inc. | d772024dex51.htm |
| S-1MEF - S-1MEF - C4 Therapeutics, Inc. | d772024ds1mef.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
C4 Therapeutics, Inc.:
We consent to the use of our report dated August 5, 2020, except as to Note 13, which is as of September 28, 2020, incorporated by reference herein.
/s/ KPMG LLP
Boston, Massachusetts
October 1, 2020